Netherlands (NL)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

MARK2 variants cause autism spectrum disorder via the downregulation of WNT/β-catenin signaling pathway (2024) Gong M, Li J, Qin Z, Machado Bressan Wilke MV, Liu Y, Li Q, Liu H, et al. Journal article Common variants increase risk for congenital diaphragmatic hernia within the context of de novo variants (2024) Qiao L, Welch CL, Hernan R, Wynn J, Krishnan US, Zalieckas JM, Buchmiller T, et al. Journal article Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group (2024) Elsayad K, Guenova E, Assaf C, Nicolay JP, Trautinger F, Stadler R, Waldstein C, et al. Journal article, Review article Within-host dynamics of antiviral treatment with remdesivir for SARS-CoV-2 infection (2024) Schuh L, Markov PV, Voulgaridi I, Bogogiannidou Z, Mouchtouri VA, Hadjichristodoulou C, Stilianakis NI Journal article Past peak prominence: the changing role of integrated assessment modelling in the IPCC (2024) Gusheva E, Pfenninger S, Lilliestam J Journal article, Original article High-density gas target at the LHCb experiment (2024) Garcia OB, Bregliozzi G, Calegari D, Carassiti V, Ciullo G, Coco V, Collins P, et al. Journal article Characterisation of the stellar wind in Cyg X-1 via modelling of colour-colour diagrams (2024) Lai EV, De Marco B, Cavecchi Y, El Mellah I, Cinus M, Diez CM, Grinberg V, et al. Journal article In Regard to Shaitelman et al. (2024) Kaidar-Person O, Strnad V, Ratosa I, Boersma L, Poortmans P Journal article Breast cancer survival prediction using an automated mitosis detection pipeline (2024) Stathonikos N, Aubreville M, de Vries S, Wilm F, Bertram CA, Veta M, van Diest PJ Journal article Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)] (2024) de Azambuja E, Piccart-Gebhart M, Fielding S, Townend J, Hillman DW, Colleoni M, Roylance R, et al. Journal article